Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exudative Age Related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Testing effectiveness (Phase 2)Study completedNCT02732899
What this trial is testing

Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD

Who this might be right for
Exudative Age Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 20
Testing effectiveness (Phase 2)UnknownNCT00745511
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Ora Bio Ltd. 96
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Large-scale testing (Phase 3)WithdrawnNCT00557791
What this trial is testing

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)

Who this might be right for
Age Related Macular Degeneration
OPKO Health, Inc.
Post-approval studies (Phase 4)Study completedNCT03355638
What this trial is testing

Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3

Who this might be right for
Macular Edema
Università degli Studi di Brescia 60
Testing effectiveness (Phase 2)Study completedNCT02181504
What this trial is testing

Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 25
Testing effectiveness (Phase 2)Ended earlyNCT04746963
What this trial is testing

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AsclepiX Therapeutics, Inc. 3
Early research (Phase 1)Study completedNCT04989699
What this trial is testing

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 21
Early research (Phase 1)Study completedNCT05639530
What this trial is testing

A Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 17
Testing effectiveness (Phase 2)Ended earlyNCT03869684
What this trial is testing

Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Senju Pharmaceutical Co., Ltd. 13
Post-approval studies (Phase 4)Ended earlyNCT00134667
What this trial is testing

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 360
Early research (Phase 1)WithdrawnNCT00538538
What this trial is testing

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal HemorrhageMacular Degeneration
Corewell Health East
Testing effectiveness (Phase 2)Looking for participantsNCT07587515
What this trial is testing

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Eyconis INC. 30
Testing effectiveness (Phase 2)UnknownNCT06183814
What this trial is testing

EXG102-031 in Participants With wAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 42
Large-scale testing (Phase 3)Study completedNCT00764738
What this trial is testing

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Retina Macula Institute 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 139
Large-scale testing (Phase 3)Study completedNCT02462486
What this trial is testing

Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 949
Early research (Phase 1)UnknownNCT01217762
What this trial is testing

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationWet Age-Related Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 62
Not applicableNot Yet RecruitingNCT07088445
What this trial is testing

Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
Hui Peng 35
Next Page